WP
ROIVW

Woodline Partners’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Woodline Partners’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-359,337
Closed -$316K – 922
2022
Q1 		$316K Hold
359,337
– – 0.01% 533
2021
Q4 		$729K Buy
+359,337
New +$548K 0.01% 533

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Woodline Partners's ROIVW Position: Q2 2022 in Review

Woodline Partners sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q2 2022, closing a stake of 359,337 shares — an estimated $316K sold.

Woodline Partners first reported a position in ROIVW in Q4 2021 and held it in 2 quarters. The position peaked at $729K in Q4 2021. 31 funds tracked by Wall St. Rank hold ROIVW as of Q2 2022.

  • Woodline Partners reported no remaining Roivant Sciences Ltd. Warrant position as of Q2 2022 after selling out during the quarter.
  • Woodline Partners sold 359,337 Roivant Sciences Ltd. Warrant shares in Q2 2022, an estimated $316K.
  • Woodline Partners first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 2 quarters.
  • Woodline Partners's Roivant Sciences Ltd. Warrant position peaked at $729K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q2 2022.

Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.